Valhi (VHI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Executive summary
The 2026 annual meeting is scheduled for May 21, 2026, with voting on director elections and executive compensation proposals.
Dixie Rice, holding 91.4% of shares, intends to vote in favor of all board proposals, ensuring passage.
Proxy materials, including the annual report and voting instructions, are available online and by mail.
Voting matters and shareholder proposals
Shareholders will vote to elect seven directors and on a nonbinding advisory resolution to approve named executive officer compensation (Say-on-Pay).
The board recommends voting FOR all director nominees and FOR the Say-on-Pay proposal.
Shareholders may submit proposals for the 2027 meeting by December 8, 2026, following SEC and bylaw requirements.
Board of directors and corporate governance
The board consists of seven members, with a majority classified as independent under NYSE standards.
Two standing committees: Audit and Management Development & Compensation, both composed of independent directors.
The chair of the board is non-executive; the CEO is a separate individual.
Directors meet regularly without management, and independent directors meet at least annually.
A code of business conduct and corporate governance guidelines are in place and available online.
Latest events from Valhi
- Shareholders will vote on director elections and executive compensation at the May 2026 meeting.VHI
Proxy filing1 Apr 2026 - Net loss in 2025 driven by weak Chemicals results, lower TiO2 prices, and higher costs.VHI
Q4 202510 Mar 2026 - Dixie Rice's majority stake ensures approval of all board and compensation proposals.VHI
Proxy Filing2 Dec 2025 - Annual meeting to elect seven directors and hold a say-on-pay vote, with online voting available.VHI
Proxy Filing2 Dec 2025 - Q3 2025 net loss of $22.2M driven by Chemicals segment decline and higher tax expense.VHI
Q3 20256 Nov 2025 - Net income dropped sharply as Chemicals weakened and interest expense increased.VHI
Q2 20257 Aug 2025 - Q3 2024 net income surged to $57.5M on Chemicals strength and LPC acquisition gains.VHI
Q3 202413 Jun 2025 - Q2 profit surged to $19.9M as Chemicals volumes rose and costs fell, despite higher interest.VHI
Q2 202413 Jun 2025 - Q1 net income surged on Chemicals growth and LPC acquisition, with a strong 2025 outlook.VHI
Q1 20256 Jun 2025